The World Health Organisation has said that “more information” is “required” from Bharat Biotech, which is seeking emergency use listing for its Covaxin vaccine for Covid-19.
The WHO website says that Bharat Biotech submitted Expression of Interest to seek approval for its vaccine on April 19 and that “more information is required”.
Also Read | Covaxin trials on children expected to begin in June: Bharat Biotech
According to the WHO, submissions to it for prequalification or listing under the emergency use procedure are confidential.
Meanwhile, Hyderabad-based Bharat Biotech has conveyed to the government that it has already submitted 90% of documents to WHO for obtaining emergency use listing for the Covaxin vaccine, PTI reported quoting sources.
The remaining documents are expected to be submitted by June, the drugmaker has told the Central government.
Also Read | Covaxin effective against India, UK coronavirus strains: Bharat Biotech